Comments
Loading...

Twist Bioscience

TWSTNASDAQ
$58.88
2.664.73%
At Close: -
$57.20
-1.68-2.85%
After Hours: 7:08 PM EDT
15 minutes delayed
Q3 2024 Earnings in 10 days from now on Fri Aug 2nd, before the market open
Consensus Rating1
Buy
Highest Price Target1
$65.00
Lowest Price Target1
$27.00
Consensus Price Target1
$46.10

Twist Bioscience (NASDAQ:TWST) Stock, Analyst Ratings, Price Targets, Forecasts

Twist Bioscience Corp has a consensus price target of $46.1 based on the ratings of 10 analysts. The high is $65 issued by TD Cowen on June 13, 2024. The low is $27 issued by Berenberg on September 27, 2023. The 3 most-recent analyst ratings were released by Goldman Sachs, Barclays, and TD Cowen on July 9, 2024, June 28, 2024, and June 13, 2024, respectively. With an average price target of $60 between Goldman Sachs, Barclays, and TD Cowen, there's an implied 4.90% upside for Twist Bioscience Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
3
May
1
Jun
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Barclays
TD Cowen
Guggenheim
Scotiabank

1calculated from analyst ratings

Analyst Ratings for Twist Bioscience

Buy NowGet Alert
07/09/2024Buy Now-3.85%Goldman Sachs
Matthew Sykes
$45 → $55MaintainsBuyGet Alert
06/28/2024Buy Now4.9%Barclays
Luke Sergott
$45 → $60MaintainsOverweightGet Alert
06/13/2024Buy Now13.64%TD Cowen
Steven Mah
$55 → $65MaintainsBuyGet Alert
06/05/2024Buy Now-7.34%Guggenheim
Subbu Nambi
→ $53Initiates → BuyGet Alert
05/06/2024Buy Now-16.08%Scotiabank
Sung Ji Nam
$43 → $48MaintainsSector OutperformGet Alert
05/03/2024Buy Now-12.59%Evercore ISI Group
Vijay Kumar
$46 → $50MaintainsOutperformGet Alert
05/03/2024Buy Now-21.33%Barclays
Luke Sergott
$40 → $45MaintainsOverweightGet Alert
05/03/2024Buy Now-30.07%Baird
Catherine Ramsey
$39 → $40MaintainsOutperformGet Alert
04/10/2024Buy Now-30.07%Barclays
Luke Sergott
$45 → $40MaintainsOverweightGet Alert
02/05/2024Buy Now-24.83%Scotiabank
Sung Ji Nam
$30 → $43MaintainsSector OutperformGet Alert
01/25/2024Buy Now-21.33%Barclays
Luke Sergott
$30 → $45MaintainsOverweightGet Alert
01/18/2024Buy Now-21.33%Goldman Sachs
Matthew Sykes
$25 → $45MaintainsBuyGet Alert
01/17/2024Buy Now-21.33%Goldman Sachs
Matthew Sykes
$25 → $45UpgradeNeutral → BuyGet Alert
09/27/2023Buy Now-52.8%Berenberg
Gaurav Goparaju
→ $27Initiates → BuyGet Alert
08/07/2023Buy Now-54.55%Barclays
Luke Sergott
$20 → $26MaintainsOverweightGet Alert
07/13/2023Buy Now-65.03%Goldman Sachs
Matthew Sykes
$18 → $20MaintainsNeutralGet Alert
05/08/2023Buy Now-68.53%Baird
Catherine Ramsey
$29 → $18MaintainsOutperformGet Alert
05/08/2023Buy Now-65.03%Barclays
Luke Sergott
$32 → $20MaintainsOverweightGet Alert
04/19/2023Buy Now-65.03%Goldman Sachs
Matthew Sykes
$43 → $20MaintainsNeutralGet Alert
04/18/2023Buy Now-65.03%Goldman Sachs
Matthew Sykes
$43 → $20MaintainsNeutralGet Alert
02/06/2023Buy Now-24.83%Goldman Sachs
Matthew Sykes
$50 → $43MaintainsNeutralGet Alert
02/06/2023Buy Now-49.3%Baird
Catherine Ramsey
$33 → $29MaintainsOutperformGet Alert
02/06/2023Buy Now-44.06%Barclays
Luke Sergott
$37 → $32MaintainsOverweightGet Alert
01/30/2023Buy Now-35.31%Barclays
Luke Sergott
$43 → $37MaintainsOverweightGet Alert
01/05/2023Buy Now-42.31%Scotiabank
Sung Ji Nam
→ $33Initiates → Sector OutperformGet Alert
01/03/2023Buy Now-37.06%Evercore ISI Group
Vijay Kumar
$28 → $36UpgradeIn-Line → OutperformGet Alert
11/21/2022Buy Now-42.31%Baird
Catherine Schulte
$56 → $33MaintainsOutperformGet Alert
11/21/2022Buy Now-24.83%Barclays
Luke Sergott
$45 → $43MaintainsOverweightGet Alert
11/21/2022Buy Now-47.55%SVB Leerink
Puneet Souda
$45 → $30MaintainsMarket PerformGet Alert
10/07/2022Buy Now-21.33%SVB Leerink
Puneet Souda
$50 → $45MaintainsMarket PerformGet Alert
10/06/2022Buy Now-21.33%Barclays
Luke Sergott
$55 → $45MaintainsOverweightGet Alert
08/08/2022Buy Now-3.85%Barclays
Luke Sergott
$45 → $55MaintainsOverweightGet Alert
08/08/2022Buy Now-12.59%SVB Leerink
Puneet Souda
$45 → $50MaintainsMarket PerformGet Alert
07/13/2022Buy Now-21.33%Barclays
Luke Sergott
$40 → $45MaintainsOverweightGet Alert
05/09/2022Buy Now-30.07%Barclays
Luke Sergott
$60 → $40MaintainsOverweightGet Alert
04/13/2022Buy Now-3.85%Goldman Sachs
Matthew Sykes
$105 → $55MaintainsNeutralGet Alert
02/07/2022Buy Now31.12%Barclays
Luke Sergott
$130 → $75MaintainsOverweightGet Alert
02/07/2022Buy Now22.38%SVB Leerink
Puneet Souda
$110 → $70MaintainsMarket PerformGet Alert

FAQ

Q

What is the target price for Twist Bioscience (TWST) stock?

A

The latest price target for Twist Bioscience (NASDAQ:TWST) was reported by Goldman Sachs on July 9, 2024. The analyst firm set a price target for $55.00 expecting TWST to fall to within 12 months (a possible -3.85% downside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Twist Bioscience (TWST)?

A

The latest analyst rating for Twist Bioscience (NASDAQ:TWST) was provided by Goldman Sachs, and Twist Bioscience maintained their buy rating.

Q

When was the last upgrade for Twist Bioscience (TWST)?

A

The last upgrade for Twist Bioscience Corp happened on January 17, 2024 when Goldman Sachs raised their price target to $45. Goldman Sachs previously had a neutral for Twist Bioscience Corp.

Q

When was the last downgrade for Twist Bioscience (TWST)?

A

There is no last downgrade for Twist Bioscience.

Q

When is the next analyst rating going to be posted or updated for Twist Bioscience (TWST)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Twist Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Twist Bioscience was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.

Q

Is the Analyst Rating Twist Bioscience (TWST) correct?

A

While ratings are subjective and will change, the latest Twist Bioscience (TWST) rating was a maintained with a price target of $45.00 to $55.00. The current price Twist Bioscience (TWST) is trading at is $57.20, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch